Mega Lifesciences Public Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mega Lifesciences Public Co Ltd with three other
pharmaceutical manufacturers in Asia:
Dongkook Pharmaceutical Company Limited
of South Korea
sales of 354.77 billion Korean Won [US$317.52 million]
of which 105%
Nippon Chemiphar Co., Ltd.
(35.69 billion Japanese Yen [US$316.56 million]
of which 97%
was Pharmaceutical Business), and
Xiangxue Pharmaceutical Co Ltd
based in China
(2.19 billion Chinese Renmimbi [US$318.85 million]
of which 37%
was Chinese Herbal Medicines).
Mega Lifesciences Public Co Ltd reported sales of 9.60 billion Thai Bahts (US$313.45 million)
December of 2017.
increase of 8.9%
versus 2016, when the company's sales were 8.81 billion Thai Bahts.
Sales at Mega Lifesciences Public Co Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 61%).
Sales of Brand saw an increase
that was more than double the company's growth rate: sales were up
19.1% in 2017, from
4.41 billion Thai Bahts to 5.26 billion Thai Bahts.
Mega Lifesciences Public Co Ltd also saw significant increases in sales in
Oem (up 16.9% to 466.55 million Thai Bahts)
Not all segments of Mega Lifesciences Public Co Ltd experienced an increase in sales in 2017:
sales of Distribution fell 3.1% to 3.87 billion Thai Bahts.